170 related articles for article (PubMed ID: 25870133)
21. Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-Ligands.
Shin IS; Maeng JS; Jang BS; You E; Cheng K; Li KC; Wood B; Carrasquillo JA; Danthi SN; Paik CH
Curr Radiopharm; 2010 Jan; 3(1):1-8. PubMed ID: 20556233
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.
Saini N; Varshney R; Tiwari AK; Kaul A; Allard M; Ishar MP; Mishra AK
Dalton Trans; 2013 Apr; 42(14):4994-5003. PubMed ID: 23389482
[TBL] [Abstract][Full Text] [Related]
23. Advances in MRI: Peptide and peptidomimetic-based contrast agents.
Pierri G; Schettini R
J Pept Sci; 2024 Mar; 30(3):e3544. PubMed ID: 37726947
[TBL] [Abstract][Full Text] [Related]
24. RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.
Ke T; Jeong EK; Wang X; Feng Y; Parker DL; Lu ZR
Int J Nanomedicine; 2007; 2(2):191-9. PubMed ID: 17722547
[TBL] [Abstract][Full Text] [Related]
25. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
26. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
[TBL] [Abstract][Full Text] [Related]
27. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
[TBL] [Abstract][Full Text] [Related]
28. A multimeric MR-optical contrast agent for multimodal imaging.
Harrison VS; Carney CE; Macrenaris KW; Meade TJ
Chem Commun (Camb); 2014 Oct; 50(78):11469-71. PubMed ID: 25137290
[TBL] [Abstract][Full Text] [Related]
29. Modified amino-dextrans as carriers of Gd-chelates for retrograde transport and visualization of peripheral nerves by magnetic resonance imaging (MRI).
Pashkunova-Martic I; Manzano-Szalai K; Friske J; Aszmann O; Theiner S; Klose MHM; Baurecht D; Trattnig S; Keppler BK; Helbich TH
J Inorg Biochem; 2021 Sep; 222():111495. PubMed ID: 34098348
[TBL] [Abstract][Full Text] [Related]
30. Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature.
Shin IS; Jang BS; Danthi SN; Xie J; Yu S; Le N; Maeng JS; Hwang IS; Li KC; Carrasquillo JA; Paik CH
Bioconjug Chem; 2007; 18(3):821-8. PubMed ID: 17375899
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.
Zarabi B; Borgman MP; Zhuo J; Gullapalli R; Ghandehari H
Pharm Res; 2009 May; 26(5):1121-9. PubMed ID: 19160028
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression.
Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM
Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289
[TBL] [Abstract][Full Text] [Related]
33. Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.
Boros E; Caravan P
J Med Chem; 2013 Feb; 56(4):1782-6. PubMed ID: 23391162
[TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
[TBL] [Abstract][Full Text] [Related]
35. Development of intravascular contrast agents for MRI using gadolinium chelates.
Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW
ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294
[TBL] [Abstract][Full Text] [Related]
36. Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging.
de Vries A; Moonen R; Yildirim M; Langereis S; Lamerichs R; Pikkemaat JA; Baroni S; Terreno E; Nicolay K; Strijkers GJ; Grüll H
Contrast Media Mol Imaging; 2014; 9(1):83-91. PubMed ID: 24470297
[TBL] [Abstract][Full Text] [Related]
37. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
[TBL] [Abstract][Full Text] [Related]
38. Exploring the Unique Contrast Properties of Aptamer-Gadolinium Conjugates in Magnetic Resonance Imaging for Targeted Imaging of Thrombi.
Koudrina A; McConnell EM; Zurakowski JA; Cron GO; Chen S; Tsai EC; DeRosa MC
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9412-9424. PubMed ID: 33395250
[No Abstract] [Full Text] [Related]
39. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
[TBL] [Abstract][Full Text] [Related]
40. [Gd(Try-TTDA)(H2O)]2-: a new MRI contrast agent for copper ion sensing.
Kasala D; Lin TS; Chen CY; Liu GC; Kao CL; Cheng TL; Wang YM
Dalton Trans; 2011 May; 40(18):5018-25. PubMed ID: 21451883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
